Lung Cancer Surgery Market

Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021

Report Code: MD 4960 Jan, 2017, by marketsandmarkets.com
COVID-19

Click here for an in-depth analysis of the COVID-19 impact on the Lung Cancer Surgery Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Lung Cancer Surgery Market

Request Now

[135 Pages Report] Lung cancer surgery is an operation performed for treating lung cancer, particularly non-small cell lung cancer. This study of the lung cancer surgery market primarily pertains to the lung cancer surgical devices market. Surgical procedures are covered separately in this report, as part of the lung cancer surgical procedures market.

The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The major factors driving the growth of this market are increasing incidence and prevalence of lung cancer, rapid growth in the aging population, and growing healthcare expenditure worldwide. On the other hand, high cost of lung cancer surgeries is the major factor that is expected to restrain the growth of this market during the forecast period.

Lung Cancer Surgery Market

Surgical Instruments segment dominated the Lung Cancer Surgery Market in 2016

Among the devices, surgical instruments are expected to account for the largest share of the market. Increasing prevalence of lung cancer across the globe has resulted in a significant increase in the number of lung cancer surgery procedures performed, which in turn is expected to fuel the market for surgical instruments during the forecast period.

Lung Cancer Surgery Market, By Device, 2016 to 2021, USD Billion

Lung Cancer Surgery Market

Minimally Invasive Surgeries are expected to grow at a fastest rate in the Lung Cancer Surgery Market in 2016

Based on procedures, the lung cancer surgery market is segmented into thoracotomy and minimally invasive surgeries segment. The thoracotomy segment further sub-segmented into lobectomy, segmentectomy, sleeve resection and pneumonectomy. Among all, minimally invasive surgeries segment is expected to grow at a highest CAGR during the forecast period. Less incisions, less hospital stay and faster recovery are the major factors that are expected fuel the growth of minimally invasive surgeries segment.

North America is expected to account for the largest share for Lung Cancer Surgery

Based on regions, the global lung cancer surgery market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in the aging population and increasing prevalence and incidence of lung cancer and availability of reimbursement for lung cancer surgeries in the region.

Market Dynamics

Driver: Technological Advancements in Lung Cancer Treatment

Currently, robot-assisted surgery, minimally invasive surgeries (such as video-assisted thoracoscopic surgeries), and percutaneous trans-catheter surgeries (such as radiofrequency ablation and cryo ablation) are some of the advanced surgical procedures that are used in the treatment of lung cancer. As compared to conventional open surgeries, these advanced procedures offer various advantages such as shorter hospital stay, shorter chest tube duration, less blood loss, and smaller incisions. As a result, the preference for these procedures is higher among patients as well as surgeons. Considering the implications of these technological advancements on patient safety, patient comfort, and surgical outcomes, the demand for technologically advanced approaches for the treatment of lung cancer is expected to increase in the coming years.

Opportunity: Untapped Emerging Markets

Emerging markets, such as China, India, and Brazil, offer significant growth opportunities for players operating in the lung cancer surgery market. These countries are expected to witness high growth in the coming years, owing to the presence of less stringent regulatory policies and low competition. Moreover, the growing prevalence of lung cancer is expected to increase the number of lung cancer surgeries in these emerging markets. According to GLOBOCAN, in 2015, the total incidence of lung cancer in emerging markets such as China, India, and Brazil was around 0.84 million and this figure is expected to reach 0.9 million by 2020. As a result of increasing disposable incomes, the healthcare expenditure in these economies is increasing rapidly. Between 2003 and 2012, growth rates for healthcare expenditure in Asia and the RoW were 11.2% and 13.9%, respectively. According to estimates from the World Bank, healthcare spending in India increased from 4.3% of GDP in 2005 to 4.7% of GDP in 2015. Additionally, growing purchasing power has enabled the patient population in emerging countries to opt for technologically advanced medical services and solutions. This in turn is expected to drive the demand for advanced medical devices, including minimally invasive surgery products, in these countries.

Scope of the Report

Report Metric

Details

Market size available for years

2014–2021

Base year considered

2016

Forecast period

2016–2021

Forecast units

Value (USD)

Segments covered

Market report covers various device, surgery, and region. On the basis of device, the market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment.

Geographies covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), and Rest of the world.

Companies covered

Major 10 players covered, including:
Ethicon US LLC (U.S.), Intutive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), and KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.) and Trokamed GmbH (Germany).

The research report categorizes the lung cancer surgery market into the following segments and sub-segments:

Lung Cancer Market, by Surgical Devices

  •  Surgical Instruments
  • Hand Instruments
    • Stapler
    • Forceps
    • Retractors
    • Rib Shear
    • Trocars
    • Cutters
    • Clamps
    • Scissors
    • Elevators
    • Other Hand Instruments
  • Monitoring and Visualizing Systems
    • Cameras and Video Support
    • Endoscopic Trocars with Optical View
  • Endosurgical Equipment

Lung Cancer Market, by Surgical Procedures

  • Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Segmentectomy
  • Pneumonectomy
  • Minimally Invasive Surgeries

Lung Cancer Surgery Market, by Region

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia
  • China
  • Japan
  • India
  • Rest of Asia
  • Rest of the World

Key Market Players:

Ethicon US LLC (U.S.), Intutive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.) and Teleflex Inc. (U.S.).

Recent Developments:


Year

Company Name

Type

Description

2016

Olympus Corporation

Expansion

Olympus Corporation opened Thai - Training and Education Center (T-TEC) in Bangkok, Thailand. The center delivers endoscopy and surgical training and education to medical practitioners in Southeast Asia.

2016

Intuitive Surgical Inc.

Collaboration

Intuitive Surgical Inc. collaborated with Fosun Pharma (China) to manufacture and sell lung cancer diagnostic and therapeutic tools in China. The devices will be innovative, robotic-assisted, and catheter-based, targeted towards early diagnosis and cost-effective treatment.

2015

Teleflex

Acquisition

Teleflex acquired N. Stenning & Co Ltd. Pty (Australia). N. Stenning is the distribution partner for Teleflex’s surgical products in Australia. This acquisition enabled the company to sell and distribute its products on a direct basis to its end-customers.

Critical questions the report answers:

  • What are the growth opportunities in the lung cancer surgery market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of lung cancer surgery products. Will this scenario continue during the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the various lung cancer surgery types and their respective market shares in the overall market?
  • What are the new trends and advancements in the lung cancer surgery market?

To know about the assumptions considered for the study, download the pdf brochure

Table of Contents
 
1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders
 
2  Research Methodology (Page No. - 17)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study
 
3 Executive Summary (Page No. - 25)
    3.1 Introduction
    3.2 Conclusion
 
4 Premium Insights (Page No. - 30)
    4.1 Lung Cancer Surgical Devices Market Overview
    4.2 Geographic Analysis: Lung Cancer Surgical Devices Market, By Type
    4.3 Lung Cancer Surgical Procedures Market, By Type, 2016-2021
    4.4 Lung Cancer Surgical Devices Market, By Region, 2016-2021
 
5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements in Lung Cancer Treatment
                    5.2.1.2 Increasing Incidence and Prevalence of Lung Cancer
                    5.2.1.3 Rising Geriatric Population
                    5.2.1.4 Increasing Number of Awareness Initiatives Aimed at Early Detection of Cancer
           5.2.2 Restraints
                    5.2.2.1 High Cost of Lung Cancer Surgeries
           5.2.3 Opportunities
                    5.2.3.1 Untapped Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 Entry Barriers for New Players
                    5.2.4.2 Dearth of Oncologists
 
6 Lung Cancer Surgical Devices Market, By Type (Page No. - 40)
    6.1 Introduction
    6.2 Surgical Instruments
           6.2.1 Hand Instruments
                    6.2.1.1 Staplers
                    6.2.1.2 Forceps
                    6.2.1.3 Retractors
                    6.2.1.4 RIB Shears
                    6.2.1.5 Trocars
                    6.2.1.6 Cutters
                    6.2.1.7 Clamps
                    6.2.1.8 Scissors
                    6.2.1.9 Elevators
                    6.2.1.10 Other Hand Instruments
    6.3 Monitoring and Visualizing Systems
           6.3.1 Cameras & Video Support
           6.3.2 Endoscopic Trocars With Optical Views
           6.3.3 Endosurgical Equipment
 
7 Lung Cancer Surgical Procedures Market, By Type (Page No. - 56)
    7.1 Introduction
    7.2 Thoracotomy
           7.2.1 Lobectomy
           7.2.2 Sleeve Resection
           7.2.3 Segmentectomy
           7.2.4 Pneumonectomy
    7.3 Minimally Invasive Surgeries
 
8 Lung Cancer Surgery Market, By Region (Page No. - 66)
    8.1 Introduction
    8.2 North America      
           8.2.1 U.S.
           8.2.2 Canada
    8.3 Europe
           8.3.1 Germany 
           8.3.2 UK 
           8.3.3 France 
           8.3.4 Spain 
           8.3.5 Italy 
           8.3.6 Rest Of Europe (RoE)
    8.4 Asia
           8.4.1 China
           8.4.2 Japan
           8.4.3 India
           8.4.4 RoA
    8.5 Rest of the World (RoW)
 
9 Lung Cancer Surgical Devices Market , Competitive Landscape (Page No. - 101)
    9.1 Introduction
    9.2 Strategic Overview
    9.3 Market Share Analysis
    9.4 Competitive Situation and Trends
           9.4.1 Agreements, Partnerships, and Collaborations
           9.4.2 Product Launches
           9.4.3 Expansions
           9.4.4 Acquisitions
           9.4.5 Other Developments
    9.5 Competitive Benchmarking 
           9.5.1 Strength of Product Portfolio (20 Players) 
           9.5.2 Business Strategy Excellence (20 Players)
 
10 Company Profiles (Page No. - 108)
     (Overview, Products and Services, Financials, Strategy & Development)* 
     10.1 Introduction
     10.2 Accuray Incorporated
             10.2.1 Business Overview
             10.2.2 Products Offered
             10.2.3 Recent Developments
             10.2.4 MnM View
     10.3 Angiodynamics Inc.
             10.3.1 Business Overview
             10.3.2 Products Offered
             10.3.3 Recent Developments
             10.3.4 MnM View
     10.4 Ethicon US, LLC (Johnson & Johnson)
             10.4.1 Business Overview
             10.4.2 Products Offered
             10.4.3 Recent Developments
             10.4.4 MnM View
     10.5 Intuitive Surgical Inc.
             10.5.1 Business Overview
             10.5.2 Products Offered
             10.5.3 Recent Developments
             10.5.4 MnM View
     10.6 Olympus Corporation
             10.6.1 Business Overview
             10.6.2 Products Offered
             10.6.3 Recent Developments
             10.6.4 MnM View
     10.7 Teleflex Incorporated
             10.7.1 Business Overview
             10.7.2 Products Offered
             10.7.3 Recent Developments
             10.7.4 MnM View
     10.8 Ackermann Instrumente GmbH
             10.8.1 Business Overview
             10.8.2 Products Offered
             10.8.3 Recent Developments
             10.8.4 MnM View
     10.9 Karl Storz GmbH
             10.9.1 Business Overview
             10.9.2 Products Offered
             10.9.3 Recent Developments
             10.9.4 MnM View
     10.1 Scanlan International, Inc.
             10.10.1 Products Offered
             10.10.2 Recent Developments
             10.10.3 MnM View
     10.11 Trokamed GmbH
             10.11.1 Products Offered
             10.11.2 Recent Developments
             10.11.3 MnM View
     *Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
 
11 Appendix (Page No. - 127)
     11.1 Insights of Industry Experts
     11.2 Discussion Guide
     11.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.4 Introducing RT: Real-Time Market Intelligence
     11.5 Available Customizations
     11.6 Related Reports
     11.7 Author Details

List of Tables (110 Tables)
 
Table 1 Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 2 Surgical Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 3 Surgical Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 4 Hand Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 5 Hand Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 6 Hand Instruments Market Size for Staplers, By Region,2014–2021 (USD Million)
Table 7 Hand Instruments Market Size for Forceps, By Region, 2014–2021 (USD Million)
Table 8 Hand Instruments Market Size for Retractors, By Region, 2014–2021 (USD Million)
Table 9 Hand Instruments Market Size for Rib Shears, By Region, 2014–2021 (USD Million)
Table 10 Hand Instruments Market Size for Trocars, By Region, 2014–2021 (USD Million)
Table 11 Hand Instruments Market Size for Cutters, By Region, 2014–2021 (USD Million)
Table 12 Hand Instruments Market Size for Clamps, By Region, 2014–2021 (USD Million)
Table 13 Hand Instruments Market Size for Scissors, By Region, 2014–2021 (USD Million)
Table 14 Hand Instruments Market Size for Elevators, By Region, 2014–2021 (USD Million)
Table 15 Other Hand Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 16 Monitoring and Visualizing Systems Market Size, By Type, 2014–2021 (USD Million)
Table 17 Monitoring and Visualizing Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Monitoring and Visualizing Systems Market Size for Cameras & Video Support, By Region, 2014–2021 (USD Million)
Table 19 Monitoring and Visualizing Systems Market Size for Endoscopic Trocars With Optical Views, By Region, 2014–2021 (USD Million)
Table 20 Endosurgical Equipment Market Size By Region, 2014–2021 (USD Million)
Table 21 Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 22 Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 23 Lung Cancer Surgical Procedures Market Size for Thoracotomy, By Type, 2014–2021 (No. of Procedures)
Table 24 Lung Cancer Surgical Procedures Market Size for Thoracotomy, By Region, 2014–2021 (USD Million)
Table 25 Lung Cancer Surgical Procedures Market Size for Thoracotomy, By Region, 2014–2021 (No. of Procedures)
Table 26 Open Lobectomy vs. Vats: Analysis of Costs, Surgery Time, and Length of Stay
Table 27 Lung Cancer Surgical Procedures Market Size for Lobectomy, By Region, 2014–2021 (No. of Procedures)
Table 28 Lung Cancer Surgical Procedures Market Size for Sleeve Resection, By Region, 2014–2021 (No. of Procedures)
Table 29 Lung Cancer Surgical Procedures Market Size for Segmentectomy, By Region, 2014–2021 (No. of Procedures)
Table 30 Lung Cancer Surgical Procedures Market Size for Pneumonectomy, By Region, 2014–2021 (No. of Procedures)
Table 31 Lung Cancer Surgical Procedures Market Size for Minimally Invasive Surgeries, By Region, 2014–2021 (USD Million)
Table 32 Lung Cancer Surgical Procedures Market Size for Minimally Invasive Surgeries, By Region, 2014–2021 (No. of Procedures)
Table 33 Lung Cancer Surgical Devices Market Size, By Region, 2014–2021 (USD Million)
Table 34 Lung Cancer Surgical Procedures Market Size, By Region, 2014–2021 (USD Million)
Table 35 Lung Cancer Surgical Procedures Market Size, By Region, 2014–2021 (No. of Procedures)
Table 36 List of Related Conferences in North America
Table 37 North America: Lung Cancer Surgical Devices Market Size, By Country, 2014–2021 (USD Million)
Table 38 North America: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 39 North America: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 40 North America: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 41 North America: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 42 U.S.: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 43 U.S.: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 44 U.S.: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 45 U.S.: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 46 Canada: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 47 Canada: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 48 Canada: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 49 Canada: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 50 Europe: Lung Cancer Surgical Devices Market Size, By Country, 2014–2021 (USD Million)
Table 51 Europe: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 52 Europe: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 53 Europe: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 54 Europe: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 55 Germany: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 56 Germany: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 57 Germany: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 58 Germany: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 59 UK: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 60 UK: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 61 UK: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 62 UK: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 63 France: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 64 France: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 65 France: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 66 France: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 67 Spain: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 68 Spain: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 69 Spain: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 70 Spain: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 71 Italy: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 72 Italy: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 73 Italy: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 74 Italy: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 75 Roe: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 76 Roe: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 77 Roe: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 78 Roe: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 79 Asia: Lung Cancer Surgical Devices Market Size, By Country, 2014–2021 (USD Million)
Table 80 Asia: Lung Cancer Surgical Procedures Market Size, By Country, 2014–2021 (No. of Procedures)
Table 81 Asia: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 82 Asia: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 83 Asia: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 84 Asia: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 85 China: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 86 China: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 87 China: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 88 China: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 89 Japan: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 90 Japan: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 91 Japan: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 92 Japan: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 93 India: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 94 India: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 95 India: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 96 India: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 97 RoA: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 98 RoA: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 99 RoA: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 100 RoA: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 101 RoW: Lung Cancer Market Size, By Surgical Devices, 2014–2021 (USD Million)
Table 102 RoW: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (USD Million)
Table 103 RoW: Lung Cancer Market Size, By Surgical Procedures, 2014–2021 (No. of Procedures)
Table 104 RoW: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 105 Growth Strategy Matrix, 2014–2016
Table 106 Agreements, Partnerships, and Collaborations, 2014–2016
Table 107 Product Launches, 2014–2016
Table 108 Expansions, 2014–2016
Table 109 Acquisitions, 2014–2016
Table 110 Other Developments, 2014–2016
 
List of Figures (44 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Lung Cancer Surgery Market: Bottom-Up Approach
Figure 4 Lung Cancer Surgery Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Lung Cancer Surgery Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 7 Global Lung Cancer Surgical Procedures Market Size, By Type, 2016 vs 2021 (No. of Procedures)
Figure 8 Global Lung Cancer Surgical Devices Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Lung Cancer Surgical Devices Market Size, By Region
Figure 10 Global Lung Cancer Surgical Devices Market to Witness Moderate Growth During the Forecast Period
Figure 11 Surgical Instruments Segment to Dominate the Global Lung Cancer Surgical Devices Market in 2016
Figure 12 Thoracotomy Segment to Dominate the Global Lung Cancer Surgery Market in 2016
Figure 13 Asian Market to Witness the Highest Growth During the Forecast Period
Figure 14 Lung Cancer Surgical Procedures Market : Drivers, Restraints, Opportunities, and Challenges
Figure 15 Market Segmentation, By Type
Figure 16 Surgical Instruments Will Continue to Dominate the Lung Cancer Surgical Devices Market During the Forecast Period
Figure 17 The Thoracotomy Segment Will Continue to Dominate the Lung Cancer Surgical Procedures Market During the Forecast Period
Figure 18 The Lobectomy Segment Will Continue to Dominate the Lung Cancer Surgical Procedures Market for Thoracotomy During the Forecast Period
Figure 19 Lung Cancer Surgical Procedures Market , By Region (Market Size and Growth Rate), 2016–2021
Figure 20 Market, By Region (No. of Procedures and Growth Rate), 2016 vs 2021
Figure 21 North America: Lung Cancer Surgery Market Snapshot
Figure 22 U.S. to Dominate the North American Lung Cancer Surgical Devices Market in 2016
Figure 23 Surgical Instruments, the Largest Segment in the North American Lung Cancer Surgical Devices Market in 2016
Figure 24 Surgical Instruments, the Largest Segment in the U.S. Lung Cancer Surgical Devices Market in 2016
Figure 25 Surgical Instruments, the Largest Segment in the Canadian Lung Cancer Surgical Devices Market in 2016
Figure 26 Surgical Instruments, the Largest Segment in the European Lung Cancer Surgical Devices Market in 2016
Figure 27 Asia: Lung Cancer Surgery Market Snapshot
Figure 28 China Estimated to Dominate the Asian Market in 2016
Figure 29 Surgical Instruments, the Largest Segment in the Asian Lung Cancer Surgical Devices Market in 2016
Figure 30 Lobectomy Surgeries Account for the Largest Share in the Asian Thoracotomy Market in 2016
Figure 31 Surgical Instruments to Hold A Major Share of the Chinese Lung Cancer Surgery Market in 2016
Figure 32 Surgical Instruments to Hold A Major Share of the Japanese Market in 2016
Figure 33 Surgical Instruments to Dominate the Indian Lung Cancer Surgical Devices Market in 2016
Figure 34 Surgical Instruments to Hold A Major Share of the RoA Market in 2016
Figure 35 Surgical Instruments to Hold A Major Share of the RoW Lung Cancer Surgery Market in 2016
Figure 36 Key Developments Witnessed in the Lung Cancer Surgery Market, 2014–2016
Figure 37 Lung Cancer Surgery Market Share Analysis, By Key Player, 2015
Figure 38 Geographic Revenue Mix of the Top Six Market Players
Figure 39 Accuray Incorporated: Company Snapshot (2015)
Figure 40 Angiodynamics Inc.: Company Snapshot (2015)
Figure 41 Johnson & Johnson: Company Snapshot (2015)
Figure 42 Intuitive Surgical Inc.: Company Snapshot (2015)
Figure 43 Olympus Corporation: Company Snapshot (2015)
Figure 44 Teleflex Incorporated: Company Snapshot (2015)

Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4960
Published ON
Jan, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Lung Cancer Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home